摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙酰氨基苯乙腈 | 25025-06-3

中文名称
4-乙酰氨基苯乙腈
中文别名
——
英文名称
N-(4-cyanomethyl-phenyl)-acetamide
英文别名
4-Acetamidophenylacetonitrile;N-[4-(cyanomethyl)phenyl]acetamide
4-乙酰氨基苯乙腈化学式
CAS
25025-06-3
化学式
C10H10N2O
mdl
MFCD00016398
分子量
174.202
InChiKey
SPAOQNOLRMENDZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    82 °C
  • 溶解度:
    >26.1 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    52.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 海关编码:
    2926909090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
  • 危险性描述:
    H302,H312,H332

SDS

SDS:e8b64554e4355680a7c7c3c3009127e7
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Acetamidophenylacetonitrile
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Acetamidophenylacetonitrile
CAS number: 25025-06-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H10N2O
Molecular weight: 174.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Amide substituted xanthine derivatives
    摘要:
    本发明是一种具有如下结构的1,3,8取代黄嘌呤衍生物(I1)或其药学上可接受的盐,其中R1、R2和R3如规范中定义。公式I的化合物及其药学上可接受的盐或前药显示出作为糖异生调节剂的活性。
    公开号:
    US20040014766A1
  • 作为产物:
    描述:
    对氨基苯乙腈乙酸酐三乙胺 作用下, 以 二氯甲烷 为溶剂, 生成 4-乙酰氨基苯乙腈
    参考文献:
    名称:
    Azetidine, pyrrolidine and piperidine derivatives
    摘要:
    一类取代的氮杂环丙烷、吡咯烷和哌啶衍生物是5-HT.sub.1-类受体的选择性激动剂,是人类5-HT.sub.1D.alpha.受体亚型的有效激动剂,同时相对于5-HT.sub.1D.beta.亚型具有至少10倍的选择性亲和力;因此,在治疗和/或预防临床疾病方面具有用处,特别是偏头痛及相关疾病,需要5-HT.sub.1D受体的亚型选择性激动剂,同时引起的副作用较少,尤其是不良心血管事件,比与非亚型选择性5-HT.sub.1D受体激动剂相关的副作用。
    公开号:
    US05854268A1
点击查看最新优质反应信息

文献信息

  • Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors
    作者:Leslie J. Street、Raymond Baker、Jose L. Castro、Mark S. Chambers、Alexander R. Guiblin、Sarah C. Hobbs、Victor G. Matassa、Austin J. Reeve、Margaret S. Beer
    DOI:10.1021/jm00063a003
    日期:1993.5
    The selectivity of these compounds for 5-HT1D receptors over other serotonergic receptors is discussed. Sulfonamide 20t shows > or = 1000-fold selectivity for 5-HT1D over 5-HT2, 5-HT1C, and 5-HT3 receptors and 10-fold selectivity with respect to 5-HT1A receptors. The functional activity of this series of compounds is studied and demonstrates high 5-HT1D receptor potency and efficacy comparable to that
    描述了一系列新的5-(恶二唑基)色胺的合成和5-HT1D受体活性。研究了恶二唑3-取代基的修饰,连接链的长度(n)和胺取代基,并揭示了5-HT1D受体域中的大结合口袋。容纳恶二唑取代基如苄基而不会损失激动剂的效力或功效。在苯基或苄基间隔基团上引入极性官能团会导致亲和力和功能效能提高10倍。当杂环与吲哚偶联时,观察到最佳的5-HT1D活性,苄基磺酰胺20t和20u代表了一些已知的最有效的5-HT1D激动剂。杂环中的S取代O导致效能进一步提高。删除恶二唑N-2不会降低活性,建议在此位置仅需要一个H键受体。讨论了这些化合物对5-HT1D受体相对于其他血清素能受体的选择性。磺酰胺20t对5-HT1D的选择性比5-HT2、5-HT1C和5-HT3受体高> 1000倍,对5-HT1A受体的选择性高10倍。研究了该系列化合物的功能活性,并证明了与5-HT相当的5-HT1D受体效能和功效。
  • [EN] HETEROCYCLIC KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE HETEROCYCLIQUE
    申请人:ABBOTT LAB
    公开号:WO2004076424A1
    公开(公告)日:2004-09-10
    Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    具有公式(I)的化合物对于抑制蛋白激酶是有用的。还公开了制造这些化合物的方法、包含这些化合物的组合物以及使用这些化合物的治疗方法。
  • Synthesis, analgesic and anti-inflammatory activities of novel 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles
    作者:Mazahar Farooqui、Rajesh Bora、C.R. Patil
    DOI:10.1016/j.ejmech.2008.05.022
    日期:2009.2
    A series of 3-(4-acetamido-benzyl)-5-substituted-1,2,4-oxadiazoles (7a–7n) were synthesized and screened for analgesic and in vivo anti-inflammatory activities using acetic acid writhing in mice model and carrageenan-induced paw oedema method in mice, respectively. The analgesic activity of compounds 7i and 7m is superior while that of 7d, 7c, 7f and 7j is equal to the reference standard, diclofenac
    合成了一系列3-(4-乙酰氨基-苄基)-5-取代-1,2,4-恶二唑(7a – 7n),并在小鼠模型和小鼠模型中使用乙酸加糖筛选了镇痛和体内抗炎活性。角叉菜胶诱发的小鼠足水肿方法。化合物7i和7m的镇痛活性优越,而7d,7c,7f和7j的镇痛活性与参考标准双氯芬酸钠相同。化合物的抗炎活性6,7C,7E,7F,图7I,发现7l,7m和7n优于用作参考的双氯芬酸钠,而发现化合物7d和7g与参考化合物等价。
  • Efficient Heterogeneous Gold(I)-Catalyzed Direct C(<i>sp</i> <sup>2</sup> )-C(<i>sp</i> ) Bond Functionalization of Arylalkynes through a Nitrogenation Process to Amides
    作者:Quan Nie、Feiyan Yi、Bin Huang、Mingzhong Cai
    DOI:10.1002/adsc.201700783
    日期:2017.11.23
    heterogeneous gold(I)-catalyzed direct C(sp2)–C(sp) bond functionalization of arylalkynes through a nitrogenation process to amides has been achieved by using an ordered mesoporous silica (MCM-41)-immobilized phosphine gold(I) complex [MCM-41-PPh3-AuCl] as catalyst and silver carbonate (Ag2CO3) as cocatalyst with trimethylsilyl azide (TMSN3) as a nitrogen source, yielding a variety of amides in moderate to
    通过使用有序介孔二氧化硅(MCM-41)固定化的磷化膦金(I),实现了第一个非均相金(I)催化的芳族炔烃通过酰胺的氮化过程直接C(sp 2)–C(sp)键的官能化)络合物[MCM-41-PPh 3 -AuCl]作为催化剂,碳酸银(Ag 2 CO 3)作为助催化剂,叠氮化三甲基硅烷基酯(TMSN 3)作为氮源,在温和条件下可产生中等至优异收率的各种酰胺。这种异质的膦金(I)络合物显示出与均相的氯(三苯基膦)金(I)相同的营业额(Ph 3PAuCl)并可以通过简单过滤反应溶液而容易地回收,并循环至少八次而没有明显的活性损失,为从炔烃合成酰胺提供了一种新颖,有效,实用和经济的方法。
  • Assembly of α‐(Hetero)aryl Nitriles via Copper‐Catalyzed Coupling Reactions with (Hetero)aryl Chlorides and Bromides
    作者:Ying Chen、Lanting Xu、Yongwen Jiang、Dawei Ma
    DOI:10.1002/anie.202014638
    日期:2021.3.22
    conditions, affording α‐(hetero)arylacetonitriles via onepot decarboxylation. Additionally, the CuBr/oxalic diamide catalyzed coupling of (hetero)aryl bromides with α‐alkyl‐substituted ethyl cyanoacetates proceeds smoothly at 60 °C, leading to the formation of α‐alkyl (hetero)arylacetonitriles after decarboxylation. The method features a general substrate scope and is compatible with various functionalities
    α-(杂)芳基腈是药物设计的重要结构图案。通过与(杂)芳基卤化物偶合直接合成这些化合物的已知方法具有狭窄的反应范围。本文中,我们报道铜盐和草酸二酰胺的结合能够在温和的条件下偶联多种(杂)芳基卤化物(Cl,Br)和氰基乙酸乙酯,从而通过一锅脱羧作用提供α-(杂)芳基乙腈。此外,(杂)芳基溴化物与α-烷基取代的氰基乙酸乙酯的CuBr /草酸二酰胺催化偶合在60°C下平稳进行,导致脱羧后形成α-烷基(杂)芳基乙腈。该方法具有一般的底物范围,并且与各种功能和杂芳基相容。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐